Potential For Sensitive Blood Test To Identify Type 1 Diabetes

Knowing who has, or will develop Type-1 diabetes is of immense clinical significance, even as the number of cases of the much more common Type-2 diabetes skyrocket. Because of technology developed at Antigen Express, the wholly-owned subsidiary of NASDAQ-listed oral insulin delivery company Generex Biotechnology, Antigen Express collaborators are now one step closer to a reliable, highly sensitive diagnostic test that will identify Type-1 diabetes patients in time for early intervention.

More: continued here

Filed under: Blood on June 10th, 2008